This timely webinar dissects the recent US MedTech regulatory landscape for a number of topics, including medical device innovation and digital transformation, AI and machine learning, US FDA product submissions, and much more. Based on a sweeping 30-page Essenvia expert report, viewers will learn strategic insights, guidance, and best practices to navigate shifting regulatory expectations in 2024 and beyond.